首页> 外文期刊>Growth Factors >Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression
【24h】

Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression

机译:胰岛素样生长因子-1和miR-486-5p在原代NK细胞和肝癌细胞系中的相互作用相互矛盾,对HCC肿瘤进展具有当代抑制作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In this study, an impaired natural killer (NK) cell cytolytic activity in 135 hepatocellular carcinoma (HCC) patients parallel to a reduced expression level of insulin-like growth factor (IGF)-1 in NK cells of HCC patients has been revealed. Ectopic expression of miR-486-5p, a direct upstream regulator of IGF-1, restored the endogenous level of IGF-1 in NK cells of HCC patients, thus augmenting its cytolytic activity against Huh7 cells in an opposite manner to the IGF-1 siRNAs. Unorthodoxly, over-expression of miR-486-5p in target hepatocytes resulted in the repression of IGF-1, suppression of Huh7 cells proliferation and viability in a similar pattern to the IGF-1 siRNAs. Therefore, this study highlights a potential role of IGF-1 in modulating cytolytic potential of NK cells of HCC patients. miR-486-5p acts in a cell-specific manner, differentially modulating IGF-1 expression in NK cells and their target hepatocytes with a contemporary inhibitory impact on HCC progression.
机译:在这项研究中,已经揭示了在135例肝细胞癌(HCC)患者中受损的自然杀伤(NK)细胞溶细胞活性,与在HCC患者的NK细胞中胰岛素样生长因子(IGF)-1表达水平降低相平行。 miR-486-5p(IGF-1的直接上游调节剂)的异位表达恢复了HCC患者NK细胞中IGF-1的内源性水平,从而以与IGF-1相反的方式增强了其对Huh7细胞的溶细胞活性siRNA。非常规地,miR-486-5p在靶肝细胞中的过表达导致了IGF-1的抑制,Huh7细胞增殖的抑制和与IGF-1 siRNA相似的生存能力。因此,本研究强调了IGF-1在调节HCC患者NK细胞溶细胞潜力中的潜在作用。 miR-486-5p以细胞特异性方式起作用,以不同的方式调节NK细胞及其靶肝细胞中IGF-1的表达,并对HCC进程产生当代抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号